AMLo Biosciences
PrivateLast Round
VC Round
Nov 28, 2022
Total Funding Raised
$5.2M
Company Overview
AMLo Biosciences operates in Healthcare & Life Sciences and is based in Newcastle upon Tyne. Its latest recorded funding round was a VC Round in November 2022.
AMLo Biosciences is a biotechnology company that develops prognostic tests for the early detection of skin cancers with metastatic potential.
Sector
Healthcare & Life Sciences
Verticals
Medical Devices, Biotechnology, Precision Medicine
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Non-AI
Historical Pricing
Historical view of private secondary pricing and transaction trends.
AMLo Biosciences Comparables
Compare AMLo Biosciences with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| SkylineDx | 81% | |
| Castle Biosciences, Inc. | 75% | |
| Myriad Genetics | 68% |
For institutional investors. Book with your work email.
AMLo Biosciences Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| VC Round | Nov 28, 2022 | ||||
| Series A | Apr 20, 2022 | ||||
| Seed | Nov 23, 2020 | ||||
| Seed | Oct 11, 2018 |
For institutional investors. Book with your work email.
AMLo Biosciences Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Ascension Ventures | Series A |
| Future Planet Capital Regional | Series A |
| Milltrust Ventures | Series A |
| Esperante | Series A, Seed, VC Round |
| Northstar Ventures | Series A, Seed, VC Round |
| Milltrust International Group | Seed |
Market signals
Structured signals derived from secondary market and firmographic data.
- Nov 28, 2022
$1.93M raised in a VC Round.
- Apr 20, 2022
$3.2M round completed.
For institutional investors. Book with your work email.
AMLo Biosciences Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about AMLo Biosciences's valuation, stock price, and market status.
Is AMLo Biosciences a public or private company?
AMLo Biosciences is a private company.
What is the current stock price of AMLo Biosciences?
AMLo Biosciences is a private company, so its shares have no public market price. Caplight tracks AMLo Biosciences's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is AMLo Biosciences worth (valuation)?
Valuation information for AMLo Biosciences is not publicly available.
Can I buy AMLo Biosciences stock?
AMLo Biosciences shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was AMLo Biosciences's last funding round?
AMLo Biosciences's most recent funding round was VC Round on November 28, 2022.
Who are the main investors in AMLo Biosciences?
Key investors in AMLo Biosciences include Esperante, Northstar Ventures.
Will AMLo Biosciences IPO soon?
No public IPO plans have been announced for AMLo Biosciences.
How can I track AMLo Biosciences secondary market activity?
Caplight tracks bids, offers, and trades in AMLo Biosciences's shares on secondary markets.